Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 9Terminated 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 46Lymphoid 27Other hematologic neoplasm 19Genitourinary 4Thoracic 3Gastrointestinal 3Myeloid 2CNS 2Breast 2Sarcoma 1Other solid neoplasm 1Head & Neck 1Gynecologic 1Endocrine 1Dermatologic 1

Conditions

Breast Neoplasms 2Neoplasm Metastasis 1

Interventions

Trastuzumab 86Cyclophosphamide 67Capecitabine 67Paclitaxel 63Docetaxel 57Fulvestrant 52Letrozole 50Carboplatin 42pembrolizumab 40Lapatinib 38Doxorubicin 36Anastrozole 32Vinorelbine 31Bevacizumab 31exemestane 28Tamoxifen 25Gemcitabine 25Albumin-Bound Paclitaxel 25Radiotherapy 21Taxes 18atezolizumab 17Everolimus 17130-nm albumin-bound paclitaxel 17pertuzumab 16Epirubicin 16palbociclib 15eribulin 14Magnetic Resonance Spectroscopy 14Ado-Trastuzumab Emtansine 14Goserelin 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Calcium Dobesilate × Breast × Clear all
NCT00253318 2025-04-27

RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer

M.D. Anderson Cancer Center

Phase 1 Terminated
15 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00832338 2017-08-31

Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores

Emory University

Phase 2 Terminated
23 enrolled 8 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡